Oral contraception and the risk of hepatocellular carcinoma.
about
Management of people with early or very early stage hepatocellular carcinoma: a network meta-analysisManagement of people with intermediate-stage hepatocellular carcinoma: a network meta-analysisNew advances in hepatocellular carcinomaStatistical tests, P values, confidence intervals, and power: a guide to misinterpretationsHepatocellular carcinoma: a reviewNon-viral causes of hepatocellular carcinoma.Hormonal contraception and risk of cancer.Oral contraceptive use among women in the military and the general U.S. populationTherapeutics Based on microRNA: A New Approach for Liver CancerNon-viral factors contributing to hepatocellular carcinoma.Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.Hormonal contraception--what kind, when, and for whom?Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project10. Cancers attributable to exposure to hormones in the UK in 2010.Hepatobiliary Quiz Answers - 18 (2016).Oral Contraceptives Use and Liver Cancer Risk: A Dose-Response Meta-Analysis of Observational Studies.Contraception in women with medical problems.Role of estrogen in liver cancer.Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan.Role of estrogen in hepatocellular carcinoma: is inflammation the key?Current concepts in pediatric liver tumors.Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.Review article: the management of cirrhosis in women.Adenoviral gene therapy in hepatocellular carcinoma: a review.Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinomaAge-specific sex difference in the incidence of hepatocellular carcinoma in the United States.Parity, age at first birth, and risk of death from liver cancer: Evidence from a cohort in Taiwan.Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.
P2860
Q24186856-5C725C14-0D32-4B77-91BD-A5CF06239AE2Q24186892-CC82B2A7-A8C3-45C3-8301-7B5A381DF64EQ26749329-98D18A01-AAA7-40CF-8D7F-0ECD00DFF314Q27316649-E8C22A9E-578D-4F03-A040-780A1ECD75BFQ28069290-2D8BB98F-AA15-4E26-B6C6-68B53F1B3277Q34041381-2A50B9A3-4F66-4B23-A6E7-2E07A5477A33Q34120493-5E375525-9A3F-41A4-B66A-FFBFCD92A6A8Q34132130-80160FA9-D88B-4FD2-8C6E-1875763458B7Q34152847-EAE7BEF4-EC43-4686-BA10-9554CAE2267DQ34653639-C2586DF6-A139-44A7-A999-E44DC88423DDQ34681207-A433CA63-8355-4DFE-9B65-5BD8B9CF1252Q35144750-1FDD14F3-3D06-4B3D-A2FE-3154E273FF27Q35274912-56247475-5498-4F6E-8A75-A2FFCD908A26Q35654702-68AD0D0D-794D-400B-894F-36407E6DC7DEQ37131606-3F370433-A85E-4695-B26E-EA27642B82A6Q37176118-1500C011-5E81-479E-A827-4DEEA44AB0B8Q37186251-24E15480-51EC-43C9-A2F9-A01E84A71724Q37346076-CFA84838-EEED-46BE-BDB4-FCAB67B65B6DQ37675836-FBEC75F4-CD14-495A-AB17-FBAD4F0C2C76Q37710885-47C74CA9-4CAE-4405-98F2-AA88FAF36891Q38007187-8B154B00-03B9-4B00-A397-846A030592B5Q38242066-01935012-08D8-4F64-920E-5050D92A6B16Q38255043-7A445BFE-C754-4F95-89A6-DA66EA28D8A7Q38552204-173710F3-B583-40D9-A0A0-9CF573706DC7Q38747707-26918A69-AD7E-4C36-9C2A-71BED892A0C9Q40696725-3F024389-08D6-4C59-9450-ADE5C72A1D47Q42366602-D224DFDA-95D2-42B2-857A-D670E945B5B7Q44678025-B72428E3-EBA6-4564-8DA0-8C489C1C0C57Q46613718-A40784CB-B511-4BB4-9909-A77685892BECQ54216177-288F4899-E866-48BD-81FA-A3B29B2A2F8F
P2860
Oral contraception and the risk of hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Oral contraception and the risk of hepatocellular carcinoma.
@ast
Oral contraception and the risk of hepatocellular carcinoma.
@en
Oral contraception and the risk of hepatocellular carcinoma.
@nl
type
label
Oral contraception and the risk of hepatocellular carcinoma.
@ast
Oral contraception and the risk of hepatocellular carcinoma.
@en
Oral contraception and the risk of hepatocellular carcinoma.
@nl
prefLabel
Oral contraception and the risk of hepatocellular carcinoma.
@ast
Oral contraception and the risk of hepatocellular carcinoma.
@en
Oral contraception and the risk of hepatocellular carcinoma.
@nl
P2093
P1476
Oral contraception and the risk of hepatocellular carcinoma.
@en
P2093
Amrou Sarraj
Hashem B El-Serag
Jennifer Kramer
Shail Maheshwari
P304
P356
10.1016/J.JHEP.2007.03.015
P577
2007-04-05T00:00:00Z